Cargando…

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

BACKGROUND: PCA3 has been included in a nomogram outperforming previous clinical models for the prediction of any prostate cancer (PCa) and high grade PCa (HGPCa) at the initial prostate biopsy (IBx). Our objective is to validate such IBx-specific PCA3-based nomogram. We also aim to optimize the use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubio-Briones, Jose, Borque, Angel, Esteban, Luis M., Casanova, Juan, Fernandez-Serra, Antonio, Rubio, Luis, Casanova-Salas, Irene, Sanz, Gerardo, Domínguez-Escrig, Jose, Collado, Argimiro, Gómez-Ferrer, Alvaro, Iborra, Inmaculada, Ramírez-Backhaus, Miguel, Martínez, Francisco, Calatrava, Ana, Lopez-Guerrero, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567811/ https://www.ncbi.nlm.nih.gov/pubmed/26362197 http://dx.doi.org/10.1186/s12885-015-1623-0

Ejemplares similares

Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced Prostate Carcinoma
por: Vidal Crespo, Natalia, et al.
Publicado: (2022)

High-Intensity Focused Ultrasound in Small Renal Masses
por: Rubio Briones, Jose, et al.
Publicado: (2008)

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
por: Pastor-Navarro, Belén, et al.
Publicado: (2021)

Rebiopsy rate after transperineal or transrectal prostate biopsy
por: Marenco Jimenez, Jose L., et al.
Publicado: (2021)

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer
por: Casanova-Salas, Irene, et al.
Publicado: (2015)

The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry
por: Borque-Fernando, Ángel, et al.
Publicado: (2017)

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
por: Mancarella, Caterina, et al.
Publicado: (2017)

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
por: Mancarella, Caterina, et al.
Publicado: (2015)

Molecular Characterization and Clinical Impact of TMPRSS2-ERG Rearrangement on Prostate Cancer: Comparison between FISH and RT-PCR
por: Fernández-Serra, A., et al.
Publicado: (2013)

Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model
por: Borque-Fernando, Ángel, et al.
Publicado: (2023)

Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images
por: Pellicer-Valero, Oscar J., et al.
Publicado: (2022)

Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
por: Pérez-Rambla, Clara, et al.
Publicado: (2017)

Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer
por: Guinot, Jose Luis, et al.
Publicado: (2022)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility
por: Rossin, Giulio, et al.
Publicado: (2023)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011)

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
por: Morote, Juan, et al.
Publicado: (2022)

A risk‐organised model for clinically significant prostate cancer early detection
por: Morote, Juan, et al.
Publicado: (2023)

Plasma Nickel Levels Correlate with Low Muscular Strength and Renal Function Parameters in Patients with Prostate Cancer
por: Alegre-Martínez, Antoni, et al.
Publicado: (2022)

Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
por: Light, Alexander, et al.
Publicado: (2022)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

Genetic Counseling in Renal Masses
por: López-Guerrero, José Antonio, et al.
Publicado: (2008)

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
por: Bilal, Muhammad, et al.
Publicado: (2022)

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2023)

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer
por: Guinot, Jose Luis, et al.
Publicado: (2015)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy
por: Buigues, Cristina, et al.
Publicado: (2020)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010)

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA)
por: Gloi, Aime M, et al.
Publicado: (2013)

PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer
por: Tamposis, Ioannis, et al.
Publicado: (2022)

Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3
por: Takita, Sarra, et al.
Publicado: (2021)

A single-center comparison of our initial experiences in treating penile and urethral cancer with video-endoscopic inguinal lymphadenectomy (VEIL) and later experiences in melanoma cases
por: Gómez-Ferrer, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ko3t4vao03sl61o6aue3ehge2i